Welcome

Pharma Futures is a multi-year, investor-led dialogue between the pharmaceutical industry and its investors about how to manage a rapidly changing operating environment to deliver long-term value both to society and to shareholders.

PF1 was a scenario planning exercise which resulted in the report, Pharma Futures: A Long-Term Value Outlook, which outlines possible future scenarios for the industry. PF2, analysed the key value drivers for the industry and society and resulted in the report, Pharma Futures 2: Prescription for Long-Term Value.



The dialogue takes place in a Working Group comprised of asset owners, sell and buy side analysts of the industry and senior pharmaceutical executives. The Working Group’s deliberations are enriched by interviews with a large number of external experts.